Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02144038 |
| Title | Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ITA | DEU | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(SC) | Houston | Texas | 77030-4009 | United States | Details | |
| Seattle Cancer Care Alliance Oncology Dept | Seattle | Washington | 98105 | United States | Details | |
| University of Wisconsin / Paul P. Carbone Comp Cancer Center Dept of Onc. | Madison | Wisconsin | 53792-6164 | United States | Details | |
| Novartis Investigative Site | Prahran | Victoria | 3181 | Australia | Details | |
| Novartis Investigative Site | Heidelberg | 69120 | Germany | Details | ||
| Novartis Investigative Site | Kiel | 24105 | Germany | Details | ||
| Novartis Investigative Site | Milano | MI | 20133 | Italy | Details | |
| Novartis Investigative Site | Singapore | 169608 | Singapore | Details |